
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Reorganization from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/reorganization/topic/12991/</link>
        <description>Articles tagged with Reorganization from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Astellas shutters OSI and Perseid, lets 200 US staff go in R&amp;D reorg</title>
          <description>It was a particularly grim Monday for 200 Astellas employees in the US, who were informed that they were being let go and it was their last day with the company.</description>
          <link>http://www.mmm-online.com/astellas-shutters-osi-and-perseid-lets-200-us-staff-go-in-rd-reorg/article/293346/</link>
          <pubDate>Tue, 14 May 2013 18:56:20 GMT</pubDate>
          <itunes:summary>It was a particularly grim Monday for 200 Astellas employees in the US, who were informed that they were being let go and it was their last day with the company.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Patent losses stalk BMS, AZ quarterly results</title>
          <description>Brass-plated brands Plavix and Seroquel continue to lose luster on the two drug makers&apos; balance sheets.</description>
          <link>http://www.mmm-online.com/patent-losses-stalk-bms-az-quarterly-results/article/290562/</link>
          <pubDate>Thu, 25 Apr 2013 17:34:05 GMT</pubDate>
          <itunes:summary>Brass-plated brands Plavix and Seroquel continue to lose luster on the two drug makers&apos; balance sheets.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>More pink slips at AstraZeneca</title>
          <description>Days after announcing a sharp downsizing, the patent expiry-plagued company said it will eliminate an additional 2,300 jobs, raising the tally of cuts to more than 5,000 through 2016.</description>
          <link>http://www.mmm-online.com/more-pink-slips-at-astrazeneca/article/285381/</link>
          <pubDate>Thu, 21 Mar 2013 15:13:01 GMT</pubDate>
          <itunes:summary>Days after announcing a sharp downsizing, the patent expiry-plagued company said it will eliminate an additional 2,300 jobs, raising the tally of cuts to more than 5,000 through 2016.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>AstraZeneca consolidates R&amp;D, moves US commercial roles</title>
          <description>AstraZeneca is cutting 650 jobs in the US, &quot;primarily in R&amp;D,&quot; and consolidating its R&amp;D operations at three &quot;strategic R&amp;D centers&quot; in &quot;bioscience clusters,&quot; academic and industrial beehives where the company can tap into concentrations of talent and infrastructure.</description>
          <link>http://www.mmm-online.com/astrazeneca-consolidates-rd-moves-us-commercial-roles/article/284899/</link>
          <pubDate>Mon, 18 Mar 2013 17:34:04 GMT</pubDate>
          <itunes:summary>AstraZeneca is cutting 650 jobs in the US, &quot;primarily in R&amp;D,&quot; and consolidating its R&amp;D operations at three &quot;strategic R&amp;D centers&quot; in &quot;bioscience clusters,&quot; academic and industrial beehives where the company can tap into concentrations of talent and infrastructure.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>AstraZeneca shakeup ousts commercial, R&amp;D chiefs</title>
          <description>AstraZeneca jettisoned its global head of commercial operations and R&amp;D chief, eliminating their roles and curtly suctioning off the company&apos;s second-highest layer of management.</description>
          <link>http://www.mmm-online.com/astrazeneca-shakeup-ousts-commercial-rd-chiefs/article/276162/</link>
          <pubDate>Tue, 15 Jan 2013 20:12:19 GMT</pubDate>
          <itunes:summary>AstraZeneca jettisoned its global head of commercial operations and R&amp;D chief, eliminating their roles and curtly suctioning off the company&apos;s second-highest layer of management.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Boehringer bails out of virology R&amp;D</title>
          <description>Boehringer Ingelheim is getting out of virology and will shut down a Quebec research facility, eliminating 170 positions in the process.</description>
          <link>http://www.mmm-online.com/boehringer-bails-out-of-virology-rd/article/259619/</link>
          <pubDate>Tue, 18 Sep 2012 20:05:52 GMT</pubDate>
          <itunes:summary>Boehringer Ingelheim is getting out of virology and will shut down a Quebec research facility, eliminating 170 positions in the process.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Endo rebrands to move beyond roots in pain drugs</title>
          <description>Endo is restructuring, bringing its four operating units under the same corporate roof and rebranding to reflect its diversification out of its origins in pain and urology drugs.</description>
          <link>http://www.mmm-online.com/endo-rebrands-to-move-beyond-roots-in-pain-drugs/article/230514/</link>
          <pubDate>Fri, 02 Mar 2012 19:14:01 GMT</pubDate>
          <itunes:summary>Endo is restructuring, bringing its four operating units under the same corporate roof and rebranding to reflect its diversification out of its origins in pain and urology drugs.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>J&amp;J says no shakeup at McNeil Consumer Healthcare unit</title>
          <description>J&amp;J is pushing back hard against a Wall Street Journal article suggesting that a pair of retirements and a promotion are part of a corporate shakeup of its recall-plagued McNeil Consumer Healthcare division.</description>
          <link>http://www.mmm-online.com/jj-says-no-shakeup-at-mcneil-consumer-healthcare-unit/article/225876/</link>
          <pubDate>Wed, 01 Feb 2012 21:03:58 GMT</pubDate>
          <itunes:summary>J&amp;J is pushing back hard against a Wall Street Journal article suggesting that a pair of retirements and a promotion are part of a corporate shakeup of its recall-plagued McNeil Consumer Healthcare division.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Ipsen to bulk up commercial team as it moves US hub to NJ</title>
          <description>Ipsen announced plans to reorganize its North American commercial operation by relocating the head office from California to New Jersey and hiring about 100 employees.</description>
          <link>http://www.mmm-online.com/ipsen-to-bulk-up-commercial-team-as-it-moves-us-hub-to-nj/article/219490/</link>
          <pubDate>Thu, 15 Dec 2011 16:28:05 GMT</pubDate>
          <itunes:summary>Ipsen announced plans to reorganize its North American commercial operation by relocating the head office from California to New Jersey and hiring about 100 employees.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Digitas Health, Razorfish Health to share new leadership, global team, in efficiency-driven reorg</title>
          <description>Digitas Health and Razorfish Health are undergoing an organizational restructure in which the two Publicis-owned siblings will share two newly appointed co-presidents, launch a single global leadership team and develop a variety of centers of excellence.</description>
          <link>http://www.mmm-online.com/digitas-health-razorfish-health-to-share-new-leadership-global-team-in-efficiency-driven-reorg/article/205975/</link>
          <pubDate>Thu, 23 Jun 2011 17:14:16 GMT</pubDate>
          <itunes:summary>Digitas Health and Razorfish Health are undergoing an organizational restructure in which the two Publicis-owned siblings will share two newly appointed co-presidents, launch a single global leadership team and develop a variety of centers of excellence.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  